Artificial Insemination Market to Grow at a CAGR of 7% by

0

USA, Rockville MD, Aug. 05, 2022 (GLOBE NEWSWIRE) — According to detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, the global artificial insemination market is expected to reach a valuation of $2.5 billion by 2026 growing at a CAGR of 7% over the forecast period (2022-2026).

A method of assisted reproduction known as artificial insemination involves injecting live sperm into a woman’s fallopian tubes, cervix, or uterus. Animal husbandry routinely uses artificial insemination to increase breeding success and protect rare and endangered species. Additionally, it helps prevent the spread of disease and infertility in animals caused by genital problems.

For critical information on Artificial insemination Market, demand a Sample report
https://www.factmr.com/connectus/sample?flag=S&rep_id=7590

The popularity of artificial insemination techniques increases when regulations are standardized across countries, as it makes patients safer. Also, donor names are kept secret under government regulations. It offers a chance to couples who wish to resort to artificial insemination. In developing countries, where around 10% of women struggle to conceive and start a family, infertility treatments are hard to come by. The market will grow if more people are made aware of infertility related issues.

Growing government initiatives to make infertility treatments more accessible, increased focus on upgrading healthcare infrastructure, and increasing number of fertility clinics are all driving the expansion of the artificial insemination market .

How is the expansion of the artificial insemination market driven?

“Growing Public Awareness of New Technologies for Reproductive Treatments”

The artificial insemination market is driven by the increasing incidence of infertility in both men and women. As more and more people develop conditions such as erectile dysfunction and polycystic ovary syndrome (PCOS), infertility is becoming more and more prevalent around the world.

Problems can arise from lifestyle changes and the desire of more working women to have children later in life. Men can find it difficult to get pregnant for a variety of reasons, including stress, alcohol use, lifestyle changes, and a decrease in sperm quantity and motility.

Artificial insemination is frequently used as the first treatment for infertility, although in vitro fertilization is considered a more sophisticated type of assisted reproductive technology.

The rapid development by multinational pharmaceutical companies of drugs in clinical and preclinical research, as well as the release of new insemination kits with proven potential benefits, are driving the growth of the artificial insemination market.

A significant opportunity has been generated for this industry by the invention of a new intracytoplasmic sperm injection (ICSI) for the production of kids, which is implanted into the egg of females.

To learn more about Artificial insemination Market, you can contact our analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7590

Key segments covered by the Artificial insemination Industry survey

  • By type:
    • Intrauterine insemination
    • Intravaginal insemination
    • Intratubal insemination
    • Others
  • By type of establishment:
    • Hospitals
    • Fertility centers
    • Home
  • By region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

Competitive landscape

Key companies are forming strategic alliances to expand their product offerings and improve their market share. Market players will exert more efforts to develop unique devices that will attract global attention.

The companies are urging regulators to quickly approve innovative pharmaceuticals and treatment regimens to expedite the introduction of advanced artificial insemination procedures.

For instance,

  • In 2022, Shenandoah Biotechnology was acquired by Fujifilm Irvine Scientific, enabling the localization of cell culture for the production of vaccines and other therapeutics.

Get customization on artificial insemination market Report for specific search solutions
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7590

The key players in the Artificial insemination Market

  • Rocket Medical PLC
  • Vitrolife AB
  • Genea Limited
  • Pride Angel Ltd.
  • Irvine Scientist
  • High-tech solutions
  • KITAZATO COMPANY

Main takeaways from Artificial insemination Market research

  • The global artificial insemination market is currently valued at US$1.9 billion.
  • The market in Japan is expected to grow at a CAGR of 6.3% through 2026.
  • The market in Canada is expected to grow at a CAGR of 5.5% over the next 4 years.
  • The demand for intravaginal insemination techniques is expected to grow at a CAGR of 6.5% from 2022 to 2026.

Explore Fact.MR’s healthcare coverage-

tissue expander market– The Global Tissue Expanders Market is estimated to be valued at USD 668.2 Million in 2022 and is projected to surpass USD 1,332.9 Million by 2032, growing at a CAGR of 7.1% from 2022 to 2032.

Non-invasive aesthetic treatment market– The size of the non-invasive aesthetic treatments market was approximately US$53.3 billion in 2021 and is expected to grow with a compound annual growth rate (CAGR) of 16.5% for the period 2022 to 2032.

Sacroiliac joint fusion market– The global Sacroiliac Joint Fusion market size is estimated at 620 Million US$ in 2022 and is projected to reach 3,900 Million US$ by 2032. The market is expected to witness a CAGR of 20.2% during of the forecast period from 2022 to 2032.

Cardiac Resynchronization Therapy Market– The Cardiac Resynchronization Therapy Industry Analysis Report recently released by Fact.MR shows that global Cardiac Resynchronization Therapy sales in 2021 held steady at US$5.7 billion. At 7.9%, the projected market growth over the period 2022-2032 is expected to be slightly lower than historical growth.
dental radiology equipment marketAccording to Fact.MR, the global dental X-ray equipment market was valued at around US$7 billion in 2020 and is expected to grow 1.4x to reach US$10 billion by 2031.

Personal Dental Water Flosser MarketAccording to Fact.MR’s research on the Personal Dental Water Flosser industry, the global market was valued at US$ 196 Million in 2020 and is projected to reach US$ 292 Million by 2031, growing at a CAGR 6% on the 2021-2031 forecasts. period.

dental diagnostic imaging equipment marketFact.MR’s research on Dental Diagnostic Imaging Equipment industry reveals that the global market was valued at US$2 Billion in 2020 and is projected to reach US$3 Billion by 2031, growing at a CAGR of 6%. Demand for X-ray systems is expected to grow at a CAGR of 5% through 2031, with that for dental cone beam tomography reaching 7%.

Dental Membranes and Bone Graft Substitutes MarketAccording to Fact.MR, the global dental membranes and bone graft substitutes market was valued at around US$500 million in 2020 and is projected to grow 1.8x to reach US$900 million by 2031.

Interdental Cleaning Products Market– Fact.MR’s Interdental Cleaning Products industry analysis shows that the global market was valued at US$3 Billion in 2020 and is projected to reach US$4 Billion by 2031, growing at a 3% CAGR. Demand for interdental brushes is expected to grow at a CAGR of 5%, reaching a valuation of around US$1 billion by 2031, with that of toothpicks increasing by 4%.

home infusion therapy market– The recently released home infusion therapy industry analysis report by Fact.MR shows that global home infusion therapy sales in 2021 held steady at US$31 billion. At 8.6%, the projected market growth between 2022 and 2032 is expected to be significantly higher than historical growth.

About Us:
Market research and consulting agency that makes the difference! That’s why 80% of Fortune 1000 companies trust us to make their most critical decisions. Although our experienced consultants use the latest technology to extract hard-to-find information, we believe that our USP is the trust our clients place in our expertise. Covering a wide range – from automotive and Industry 4.0 to healthcare and retail, our coverage is extensive, but we ensure that even the most niche categories are analyzed. Our sales offices in the USA and Dublin, Ireland. Headquarters based in Dubai, United Arab Emirates. Contact us with your goals and we will be a competent research partner.

Contact:
Mahendra Singh
USA Sales Office:
11140 Rockville Pike
Office 400
Rockville, MD 20852
Email: [email protected]
Tel: +1 (628) 251-1583
Follow us: LinkedIn | Twitter


Source link

Share.

Comments are closed.